河北医科大学学报

• 论著 • 上一篇    下一篇

辅助卵母细胞激活技术在体外受精中的临床应用#br#

  

  1. 河北医科大学第二医院生殖医学科,河北 石家庄 050000
  • 出版日期:2019-12-25 发布日期:2019-12-26
  • 作者简介:王跃(1986-),男,云南大理人,河北医科大学第二医院主管检验师,医学学士,从事生殖医学研究。
  • 基金资助:
    河北省科技计划项目(16277731D)

Clinical application of assisted oocyte activation in in vitro fertilization#br#

  1. Department of Pediatrics, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  • Online:2019-12-25 Published:2019-12-26

摘要: [摘要]
  目的  观察辅助卵母细胞激活(assisted oocyte activation,AOA)技术在体外受精周期中的应用,并对受精、胚胎发育情况、临床结局等激活效果进行评价。
  方法  回顾性分析进行卵胞浆内单精子显微注射(intracytoplasmic sperm injection,ICSI)联合AOA处理的23例助孕者的临床资料,观察卵母细胞激活后的原核形成、胚胎发育情况及临床结局等。
  结果  23例共进行23周期的ICSI+AOA,全部采用钙离子载体A23187进行激活处理,9例获得临床妊娠,临床妊娠率为39.1%。其中至少有1次ICSI完全受精失败8例(A组),AOA周期的2PN受精率、2PN卵裂率、优质胚胎率和可利用胚胎率分别为50.0%、93.3%、39.3%和71.4%,临床妊娠率和胚胎种植率分别为12.5% 和7.1%;精子严重畸形(如圆头精子症等)15例(B组),AOA周期的2PN受精率、2PN卵裂率、优质胚胎率和可利用胚胎率分别为53.9%、98.8%、48.8%和65.9%,临床妊娠率和胚胎种植率分别为53.3%和40.7%。
  结论  AOA可以改善ICSI完全受精失败者的受精率及胚胎发育质量,并可用于严重精子畸形如圆头精子症的ICSI,对临床应用有一定的价值。

关键词: 辅助卵母细胞激活, 受精失败, 卵胞浆内单精子注射

Abstract: [Abstract]Objective〖HTSS〗To observe the application of assisted oocyte activation(AOA) in the in vitro fertilization cycle, and to evaluate the activation effects of fertilization, embryo development, and clinical outcomes.
  〖WTHZ〗Methods〖HTSS〗This retrospective analysis was conducted on infertile women undergoing intracytoplasmic sperm injection(ICSI) combined with AOA treatment(23 cases in total). The pronucleus formation, embryo development and clinical outcomes of oocytes after activation in these patients were observed.
  〖WTHZ〗Results〖HTSS〗Each patient of this study underwent one cycle of ICSI+AOA, all of the oocytes were activated by calcium ionophore A23187. Ultimately 9 patients received clinical pregnancy. The clinical pregnancy rate was 39.1%. Group A: This group included 8 cases of ICSI total fertilization failure at least one time. The 2PN fertilization rate, 2PN cleavage rate, excellent embryo rate and available embryo rate of AOA cycle were 50.0%, 93.3%, 39.3% and 71.4%, respectively. The clinical pregnancy rate and implantation rate were 12.5% and 7.1%, respectively. Group B: This group included ten cases of severe sperm deformity, such as round head sperm disease. The 2PN fertilization rate, 2PN cleavage rate, excellent embryo rate and available embryo rate of AOA cycle were 53.9%, 98.8%, 48.8%, and 65.9%, respectively.The clinical pregnancy rate and planting rate were 53.3% and 40.7%, respectively.
  〖WTHZ〗Conclusion〖HTSS〗AOA can improve the fertilization rate and embryo development quality of patients with total fertilization failure in ICSI, and can be used for ICSI of severe sperm deformity such as round head sperm disease, which has certain value for clinical application.

Key words: assisted oocyte activation, fertilization failure, intracytoplasmic sperm injection